Hospira, Inc. HSP, the world's leading provider of injectable drugs
and infusion technologies, and Q Core Medical, Ltd., an innovation leader in
infusion delivery systems, today announced that the companies have entered
into a distribution agreement for the Q Core Sapphire™ multi-therapy infusion
system. Through the arrangement, Hospira will have exclusive rights to market
and distribute Sapphire -- a compact and lightweight infusion device system
frequently used in ambulatory and hospital settings -- in more than 60 key
markets across Europe, Asia and The Americas. The agreement also enables
Hospira to collaborate with Q Core for distribution of its product development
pipeline.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in